双鹭药业 (002038)

Beijing SL Pharmaceutical Co., Ltd.

ASZ

Tags

Nicotinamide Mononucleotide (NMN) ConceptWeight Loss DrugsVenture Capital ConceptInnovative DrugsMedical Aesthetics ConceptPharmaceutical ManufacturingGene ConceptCCTV 50 IndexIndustrial HempHelicobacter PyloriSmart HealthcarePrivate HospitalsBiological VaccinesHepatitis ConceptMargin Trading and Securities LendingAssisted ReproductionSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 102735.00
  • Circulating A-Shares(W): 85191.35
  • Earnings Per Share(RMB): 0.1373
  • Net Assets Per Share(RMB): 5.5414
  • Operating Revenue(W RMB): 45875.26
  • Total Profit(W RMB): 15885.97
  • Net Profit Attributable to Parent(W RMB): 14109.80
  • Net Profit Growth Rate(%): 943.10
  • Weighted Return on Equity(%): 2.5000
  • Operating Cash Flow Per Share(RMB): -0.0060
  • Undistributed Profit Per Share(RMB): 3.8645
  • Capital Reserve Per Share(RMB): 0.0483

2. Main Business

The main business covers:

  • Research, development, production and operation of genetic engineering and related drugs

3. Company Basic Information

  • Company Name: Beijing SL Pharmaceutical Co., Ltd.
  • Listing Date: 2004-09-09
  • Industry: Pharmaceutical Manufacturing
  • Address: Building 1, Bitong Garden, No. 69 Fushi Road, Haidian District, Beijing
  • Website: www.slpharm.com.cn
  • Company Profile: Approved by the Beijing Municipal Government Document Jing Zheng Han [2000] No. 86 "Notice on Agreeing to Change Beijing Shuanglu Pharmaceutical Co., Ltd. to Beijing Shuanglu Pharmaceutical Co., Ltd.", the issuer was changed from a limited liability company to a joint stock company on August 9, 2000.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Xinxiang Bailu Investment Group Co., Ltd. Corporate 15974.00 18.75
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1212.13 1.42
3 Southern China Securities CSI 1000 ETF Fund 658.87 0.77
4 China Galaxy Securities Co., Ltd. - Stock Repurchase Special Account Corporate 589.87 0.69
5 ChinaAMC CSI 1000 ETF Fund 390.85 0.46

5. Concept Sectors

  • Venture Capital
  • Biological Vaccine
  • Private Hospital
  • Gene Concept
  • Smart Healthcare
  • Industrial Hemp
  • Medical Aesthetics
  • NMN Concept
  • Helicobacter Pylori
  • Assisted Reproduction
  • Hepatitis Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Margin Trading
  • CCTV 50
  • SME 300

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information